The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Proteome expects FY profits to be 'materially higher' than previous guidance

Fri, 26th Mar 2021 08:37

(Sharecast News) - Protein biomarker research and development firm Proteome Sciences said on Friday that it has been progressing with a year-end audit and now expects to announce its 2020 full-year results on 1 April.
Proteome Sciences stated that it now expects to report after-tax profits "materially higher" than announced at the time of its last update on 25 January, primarily due to higher than expected royalty receipts from Thermo Scientific for the final quarter of 2020.

However, the AIM-listed group added that its annual results were still subject to finalisation of the audit and approval by its board.

As of 0835 GMT, Proteome shares had surged 30.82% to 4.96p.

Related Shares

More News
16 May 2024 12:23

IN BRIEF: Proteome Sciences promises AGM return to growth in 2024

Proteome Sciences PLC - London-based protein-focused drug development services provider - Proteome tells annual general meeting on Thursday it is "con...

16 May 2024 10:41

AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrome...

26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's ma...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.